The Italian newspaper “Lastamba” reported that the European Union may not extend contracts with “AstraZeneca” and “Johnson & Johnson” regarding their anti-Corona virus vaccines for the next year.
The newspaper indicated that Italian Prime Minister Mario Draghi and other European heads of government will decide not to extend contracts with companies that produce vaccines based on the viral vector technology.
The restrictions may also affect the Russian “Sputnik V” vaccine, which has not yet been authorized by the European Medicines Agency, and the Italian Reithera vaccine.
From next year, Italy and other European Union countries will use only the “Pfizer” and “Moderna” vaccines, which are both messenger RNA vaccines.
According to the newspaper, the second option is under study and requires an extension of contracts, but with a reduction in the amount of doses provided under it, and a shortening of the use of viral vector vaccines for people over the age of 60 years, as the available data indicate that they are not exposed to blood clots after receiving this type of vaccination.
It is noteworthy that many European countries have suspended the use of the “AstraZeneca” vaccine, after reports of blood clots that may be related to the use of the vaccine, and Denmark announced that it abandoned the use of the “AstraZeneca” vaccine completely.
After AstraZeneca, the Johnson & Johnson vaccine raised concerns for the same reasons.
Source: “Lastamba” newspaper